XSS in Bdtask G-Prescription Gynaecology \& Obs Consultation
CVE-2024-2276
A vulnerability has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this vulnerability is an unknown functionality of the file /Venue_controller/edit_venue/ of the component Edit Venue Page. The manipulation of the argument Venue map leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-256045 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Vulnerability class: XSS (Cross-Site Scripting)
EPSS: 0.005 (39.2th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.
Affected products
- Bdtask G-prescription_gynaecology_\&_obs_consultation — versions 1.0
- Bdtask G-prescription Gynaecology & Obs Consultation Software — versions 1.0
Weakness classification (CWE)
Public proof-of-concept exploits
References
- cna@vuldb.com (Permissions Required, technical-description, vdb-entry)
- cna@vuldb.com (signature, Permissions Required, permissions-required)
- cna@vuldb.com (Exploit, exploit)
Frequently asked questions
- What is CVE-2024-2276?
- CVE-2024-2276 is a low-severity vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2024-03-08.
- How severe is CVE-2024-2276?
- Low severity. CVSS v3 base score is 2.4 out of 10.
- Is CVE-2024-2276 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.